LBRX
LB Pharmaceuticals Inc
44.71
-0.23 (-0.51%)
52w low 14.40
50.16 high
84.8% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | 49.8% | 18.2% | 66.7% | -8.4% | |
| Return on Assets | -66.8% | -13.7% | -188.2% | -8.1% | |
| Return on Inv Capital | 261.5% | 4.2% | 68.6% | -10.1% | |
| Liquidity | |||||
| Current Ratio | 45.82x | 17.51x | 3.56x | 41.44x | |
| Quick Ratio | 45.82x | 17.51x | 3.56x | 41.44x | |
| Cash Ratio | 45.64x | 5.75x | 2.83x | 33.62x | |
| Leverage | |||||
| Debt / Equity | -0.84x | -0.00x | -0.04x | 0.01x | |
| Net Debt / EBITDA | -0.23x | -- | -- | -- | |
| Interest Coverage | -5.67x | -0.30x | -- | -- | |
| Equity Multiplier | -0.75x | -1.32x | -0.35x | 1.04x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -0.0% | -0.0% | -0.0% | -0.0% | |
| Op CF / Net Income | 0.19x | 1.93x | 0.84x | 1.40x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--